Cargando…

Comparison of clinical outcomes between sorafenib and hepatic artery infusion chemotherapy in advanced hepatocellular carcinoma: A STROBE-compliant article

Sorafenib is the most widely used multikinase inhibitor in patients with advanced hepatocellular carcinoma (HCC). Despite its efficacy, only a small proportion of patients experience tumor regression. Hepatic artery infusion chemotherapy (HAIC) can be used as an alternative treatment for HCC. A tota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Min Kyu, Park, Jung Gil, Lee, Heon Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5944539/ https://www.ncbi.nlm.nih.gov/pubmed/29703062 http://dx.doi.org/10.1097/MD.0000000000010611

Ejemplares similares

Sorafenib plus hepatic arterial infusion chemotherapy with oxaliplatin versus sorafenib alone for advanced hepatocellular carcinoma
por: Zhao, Yang, et al.
Publicado: (2019)

Treatment strategies for advanced hepatocellular carcinoma: Sorafenib vs hepatic arterial infusion chemotherapy
por: Saeki, Issei, et al.
Publicado: (2018)

Clinical analysis of neoadjuvant chemotherapy in patients with advanced vulvar cancer: A STROBE-compliant article
por: Niu, Yizhen, et al.
Publicado: (2018)

A meta-analysis comparing hepatic arterial infusion chemotherapy and sorafenib for advanced hepatocellular carcinoma
por: Yan, Leye, et al.
Publicado: (2022)

Sorafenib plus hepatic arterial infusion chemotherapy with cisplatin versus sorafenib for advanced hepatocellular carcinoma: randomized phase II trial
por: Ikeda, M., et al.
Publicado: (2016)

Trends in dacryocystitis in China: A STROBE-compliant article
por: Chen, Lijuan, et al.
Publicado: (2018)

Low Expression of LDHB Correlates With Unfavorable Survival in Hepatocellular Carcinoma: Strobe-Compliant Article
por: Chen, Ruohua, et al.
Publicado: (2015)

Sorafenib combined with embolization plus hepatic arterial infusion chemotherapy for inoperable hepatocellular carcinoma
por: Liu, Bao-Jiang, et al.
Publicado: (2020)

Hepatic Arterial Infusion Chemotherapy of Oxaliplatin, Fluorouracil, and Leucovorin With or Without Sorafenib as Initial Treatment for Advanced Hepatocellular Carcinoma
por: Liang, Run-Bin, et al.
Publicado: (2021)

Sorafenib Plus Hepatic Arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-analysis
por: Peng, Peichun, et al.
Publicado: (2023)

Efficacy and safety of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma as first-line therapy
por: Oh, Myung Jin, et al.
Publicado: (2013)

Postsurgical treatment with adjuvant transarterial chemoembolization in patients with hepatitis B-related hepatocellular carcinoma: A strobe-compliant article
por: Hu, Hao, et al.
Publicado: (2016)

Evaluation of the association between hyperuricemia and coronary artery disease: A STROBE-compliant article
por: Lan, Ming, et al.
Publicado: (2018)

Metabolic characteristics of obese children with fatty liver: A STROBE-compliant article
por: Zhao, Kanglu, et al.
Publicado: (2019)

Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Ahn, Young Eun, et al.
Publicado: (2021)

Efficacy of cataract surgery in patients with uveitis: A STROBE-compliant article
por: Zhang, Yinglei, et al.
Publicado: (2017)

The gap between overweight and obesity status in children - (STROBE-compliant article)
por: Mărginean, Cristina Oana, et al.
Publicado: (2021)

Survival Benefit of Hepatic Arterial Infusion Chemotherapy over Sorafenib in the Treatment of Locally Progressed Hepatocellular Carcinoma
por: Iwamoto, Hideki, et al.
Publicado: (2021)

Effect of body composition on survival benefit of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: A comparison with sorafenib therapy
por: Saeki, Issei, et al.
Publicado: (2019)

Hepatic Arterial Infusion Chemotherapy with Cisplatin versus Sorafenib for Intrahepatic Advanced Hepatocellular Carcinoma: A Propensity Score-Matched Analysis
por: Zaizen, Yuki, et al.
Publicado: (2021)

Hepatic Arterial Infusion Chemotherapy for Advanced Hepatocellular Carcinoma in Japan
por: Nishikawa, Hiroki, et al.
Publicado: (2012)

Natural course and outcomes of spontaneous isolated celiac artery dissection according to morphological findings on computed tomography angiography: STROBE compliant article
por: Kim, Bohyun, et al.
Publicado: (2018)

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
por: Kondo, Masaaki, et al.
Publicado: (2019)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis
por: Deng, Min, et al.
Publicado: (2023)

Measuring the sense of self in brain-damaged patients: A STROBE-compliant article
por: Hiromitsu, Kentaro, et al.
Publicado: (2018)

The usefulness of inflammatory biomarkers in diagnosing child and adolescent's gastritis: STROBE compliant article
por: Meliţ, Lorena Elena, et al.
Publicado: (2019)

Revisiting Hepatic Artery Infusion Chemotherapy in the Treatment of Advanced Hepatocellular Carcinoma
por: Chen, Ching-Tso, et al.
Publicado: (2021)

Phase I study of combination chemotherapy using sorafenib and transcatheter arterial infusion with cisplatin for advanced hepatocellular carcinoma
por: Hagihara, Atsushi, et al.
Publicado: (2014)

Evaluation of sorafenib treatment and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a comparative study using the propensity score matching method
por: Fukubayashi, Kotaro, et al.
Publicado: (2015)

Hepatic arterial infusion chemotherapy versus sorafenib for advanced hepatocellular carcinoma with portal vein tumor thrombus: An updated meta-analysis and systematic review
por: Zhang, Wei, et al.
Publicado: (2023)

Comments on Comparison of Sorafenib versus Hepatic Arterial Infusion Chemotherapy-Based Treatment for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: Reply
por: Yim, Hyung Joon, et al.
Publicado: (2023)

Molecular characteristics of colorectal serrated polyps and hyperplastic polyps: A STROBE compliant article
por: Sambuudash, Otgontuya, et al.
Publicado: (2016)

Identification of predictors for acute postoperative pain after gynecological laparoscopy (STROBE-compliant article)
por: Joo, Jin, et al.
Publicado: (2019)

Differential impacts of hemolysis on coagulation parameters of blood samples: A STROBE-compliant article
por: Pan, Lin-Lin, et al.
Publicado: (2021)

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma in the era of chemo-diversity
por: Iwamoto, Hideki, et al.
Publicado: (2023)

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): an open label, non-comparative, phase II trial
por: Hatooka, Masahiro, et al.
Publicado: (2018)

A case report of advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy and sorafenib combination therapy followed by metastasectomy of lung and muscle metastases
por: Moon, Sang Yi, et al.
Publicado: (2022)

Impact of Coexisting Pulmonary Diseases on Survival of Patients With Lung Adenocarcinoma: A STROBE-Compliant Article
por: Jian, Zhi-Hong, et al.
Publicado: (2015)

Efficacy of Surgery and Adjuvant Therapy in Older Patients With Colorectal Cancer: A STROBE-compliant article
por: Yang, Lie, et al.
Publicado: (2014)

STROBE-compliant article: Is continuity of care associated with avoidable hospitalization among older asthmatic patients?
por: Kao, Yu-Hsiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_j2t4bujt27mqer38cimcqtcajk